ABVC BIOPHARMA INC

NASDAQ: ABVC (ABVC Biopharma, Inc.)

Last update: yesterday, 12:45PM

0.983

0.01 (0.69%)

Previous Close 0.976
Volume 36,408
Price / Sales 27.42
Price / Book 2.53
52 Weeks Range
0.707 (-28%) — 3.40 (245%)
Operating Margin (TTM) -503.56%
Diluted EPS (TTM) -0.190
Quarterly Revenue Growth (YOY) -9.20%
Total Debt/Equity (MRQ) 36.22%
Current Ratio (MRQ) 0.220
Operating Cash Flow (TTM) -1.39 M
Levered Free Cash Flow (TTM) -2.07 M
Return on Assets (TTM) -10.91%
Return on Equity (TTM) -42.42%

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Mixed Bullish
Biotechnology (Global) Mixed Bullish
Stock ABVC Biopharma, Inc. - -

AIStockmoo Score

1.4
Analyst Consensus NA
Insider Activity NA
Price Volatility 0.5
Technical Moving Averages 5.0
Technical Oscillators 2.0
Average 1.43

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
ABVC - - - 2.53
MNMD 1 B - - 5.42
IPA 96 M - - 5.98
THAR 7 M - - 28.74
ELDN - - - 6.84
XLO - - - 0.820

ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.

Sector Healthcare
Industry Biotechnology
Investment Style Small Value
% Held by Insiders 16.47%
% Held by Institutions 2.28%

Ownership

Name Date Shares Held
Panagora Asset Management Inc 30 Jun 2026 36,682

No data within this time range.

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria